Science Explorer Back to mapMap
Discussion
Company · Chichester · United Kingdom

Profile Pharma (United Kingdom)

profilepharma.comROR OpenAlex
Research works
3
fractional, all time
Citations
238
92.2 per fractional work
Top-10% rate
48.4%
all institutions 10.0%
Open access
10%
world 40%
International
23%
world 18%
Profile Pharma (United Kingdom)

Not ranked overall: Profile Pharma (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Profile Pharma (United Kingdom) work in?

In all years, 69% of research at Profile Pharma (United Kingdom) is in Health Sciences, 27% in Social Sciences. Its largest fields are Medicine (62%), Economics, Econometrics and Finance (27%), Health Professions (8%). It does 1.3× the world's share of Health Sciences.

Health Sciences: 2 fractional works · 69.2% of its workMedicine: 2 fractional works · 61.5% of its workHealth Professions: 0 fractional works · 7.7% of its workSocial Sciences: 1 fractional works · 26.9% of its workEconomics, Econometrics and Finance: 1 fractional works · 26.9% of its workLife Sciences: 0 fractional works · 3.8% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 3.8% of its workALL ITS WORKProfile Pharma(United Kingdom)3fractional works, all years
Life Sciences4%Health Sciences69%Social Sciences27%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Medicine261.5%
    2. Health Professions07.7%
    1. Economics, Econometrics and Finance126.9%
    1. Biochemistry, Genetics and Molecular Biology03.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Profile Pharma (United Kingdom)?

The most cited paper from Profile Pharma (United Kingdom) is "Inhaled Colistin in Patients with Bronchiectasis and Chronic Pseudomonas aeruginosa Infection" (Charles Haworth, Juliet E. Foweraker, Peter R. Wilkinson et al., 2014), with 264 citations. Next come "Repurposing Strategies for Therapeutics" (166) and "Domiciliary Experience of the Target Inhalation Mode (TIM) Breathing Maneuver in Patients with Cystic Fibrosis" (20).

Most cited papers
#PaperReleasedCitations
1 Inhaled Colistin in Patients with Bronchiectasis and Chronic Pseudomonas aeruginosa Infection Charles Haworth, Juliet E. Foweraker, Peter R. Wilkinson et al. · American Journal of Respiratory and Critical Care Medicine Open access 13 Mar 2014 264
2 Repurposing Strategies for Therapeutics Sara H. Sleigh, Cheryl L. Barton · Pharmaceutical Medicine Jun 2010 166
3 Domiciliary Experience of the Target Inhalation Mode (TIM) Breathing Maneuver in Patients with Cystic Fibrosis John Denyer, A.M.S. BLACK, Kurt Nikander et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery Open access Apr 2010 20
4 Adherence with inhaled colistimethate sodium during a 6 month study in patients with non-cystic fibrosis bronchiectasis Charles Haworth, Diana Bilton, Robert Kenyon · European Respiratory Journal Sep 2013 3
5 Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonised by pseudomonas aeruginosa Charles Haworth, Diana Bilton, Robert Kenyon · European Respiratory Journal Sep 2013 2
All 5 most cited papers, with filters and sorting

Which research topics does Profile Pharma (United Kingdom) publish most on?

By volume: Cystic Fibrosis Research Advances, Biotechnology and Related Fields, Health Systems, Economic Evaluations, Quality of Life and Pharmaceutical Economics and Policy.

Cystic Fibrosis Research…0Cystic Fibrosis Research Advances: 0 fractional worksBiotechnology and Related Fields: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksPharmaceutical Economics…0Pharmaceutical Economics and Policy: 0 fractional worksPharmaceutical studies and practices: 0 fractional worksMedication Adherence and Compliance: 0 fractional worksPediatric health and respiratory diseases: 0 fractional worksGastroesophageal reflux and treatments: 0 fractional worksDialysis and Renal Disease Management: 0 fractional worksInhalation and Respiratory Drug Delivery: 0 fractional works
Pulmonary and Respiratory MedicinePublic Health, Environmental and Occupational HealthEconomics and EconometricsPediatrics, Perinatology and Child Health4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works
  2. 2 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 0 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  4. 4 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  5. 5 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  6. 6 Medication Adherence and Compliance Family Practice 0 works
  7. 7 Pediatric health and respiratory diseases Emergency Medical Services 0 works
  8. 8 Gastroesophageal reflux and treatments Gastroenterology 0 works
  9. 9 Dialysis and Renal Disease Management Nephrology 0 works
  10. 10 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available9.7%not open90.3%

World: 40% of research is openly available.

with international co-authors22.6%domestic only77.4%

World: 18% is written across borders.

How has Profile Pharma (United Kingdom)'s research output changed?

Other research institutions in Chichester

All research institutions in Chichester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Profile Pharma (United Kingdom). Posts are plain text and can be reported.